Expert Ratings for Amylyx Pharma
Portfolio Pulse from Benzinga Insights
Amylyx Pharma (NASDAQ:AMLX) has received five bullish analyst ratings in the last quarter, with an average price target of $49.8, indicating a potential upside from the current price of $21.55. The average price target has increased by 2.68% over the past month.
August 11, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Amylyx Pharma has received positive analyst ratings, which could potentially drive its stock price up in the short term.
Analyst ratings often influence investor sentiment and can impact a company's stock price. In this case, Amylyx Pharma has received five bullish ratings, which indicates a positive outlook for the company's stock. This could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100